Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

First-line Treatment with Sparsentan, a Dual Endothelin and Angiotensin Receptor Antagonist, in Patients with Immunoglobulin A Nephropathy: Initial Results of the SPARTAN Study

Matthew Sayer,Jonathan Barratt, Colleen Burns,Neeraj Dhaun,Sian Griffin, Alexandra Howson,Radko Komers,Alex Mercer, Smeeta Sinha,Lisa Willcocks,Chee Kay Cheung

CLINICAL SCIENCE（2024）

Cited 0|Views0
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined